

Everything you need to know about Symproic (Naldemedine) — what it treats, how to take it, dosage, side effects, cost, and more. Updated 2026.
Symproic is the brand name for Naldemedine, a prescription medication used to treat opioid-induced constipation (OIC) in adults with chronic non-cancer pain. It was approved by the FDA in March 2017 and is manufactured by Shionogi Inc.
Symproic belongs to a class of drugs called peripherally-acting mu-opioid receptor antagonists (PAMORAs). In simple terms, it blocks the effects of opioids in your gut — helping your bowels move normally again — without interfering with the pain relief your opioids provide.
Outside the United States, the same medication is sold under the brand name Rizmoic.
Symproic is specifically approved to treat opioid-induced constipation. OIC is a common side effect of opioid pain medications like Oxycodone, Hydrocodone, Morphine, and Fentanyl. When you take opioids, they don't just block pain signals — they also slow down your digestive system, leading to constipation that can be severe and persistent.
Unlike regular constipation, OIC doesn't always respond to standard treatments like fiber supplements, stool softeners, or over-the-counter laxatives. That's where Symproic comes in.
It's important to note that Symproic is only approved for OIC in patients with chronic non-cancer pain in the U.S. In Europe and Japan, it's also approved for OIC in cancer patients under the Rizmoic brand.
Opioid medications activate receptors throughout your body — including in your brain (for pain relief) and in your gut (which causes constipation). Symproic works by blocking the opioid receptors in your gastrointestinal tract without significantly crossing the blood-brain barrier.
This means your gut starts working normally again while your pain medication continues to do its job. For a more detailed explanation, see our article on How Does Symproic Work? Mechanism of Action Explained.
Symproic comes as a 0.2 mg oral tablet. The standard dose is:
There's only one dose strength available, so there's no dose adjustment needed for most patients. However, you should avoid Symproic if you have severe liver disease (Child-Pugh Class C).
Important: If you stop taking your opioid medication, you should also stop taking Symproic. The medication is only needed while you're on opioid therapy.
Symproic is approved for adults (18 and older) who:
You should not take Symproic if you have:
Tell your doctor if you have a history of GI conditions like peptic ulcers, diverticulitis, Crohn's disease, or GI cancers, as these may increase the risk of serious complications.
No. When Symproic was first approved in 2017, it was briefly placed in Schedule II. However, the DEA removed it from all controlled substance schedules in September 2017 after determining it has no abuse potential. This makes it easier to prescribe and refill compared to some other medications.
The most common side effects of Symproic include:
These are usually mild and tend to improve within the first few days. For a complete breakdown, read our guide on Symproic Side Effects: What to Expect.
Symproic can interact with other medications. The most important ones to know about:
For the full list, see Symproic Drug Interactions: What to Avoid.
Without insurance, Symproic costs between $484 and $746 for a 30-day supply (30 tablets). There is currently no generic version of Naldemedine available, which keeps the price high.
Ways to save on Symproic:
For more details, read How to Save Money on Symproic.
Symproic is one of several PAMORAs available for OIC treatment:
Symproic's advantages include once-daily dosing, the ability to take it with or without food, and no controlled substance restrictions. For a deeper comparison, see Alternatives to Symproic.
Because Symproic is a brand-name specialty medication, not every pharmacy stocks it. Use MedFinder to check which pharmacies near you have it in stock, or read our guide on How to Check If a Pharmacy Has Symproic in Stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.